MYC and colorectal cancer: Low-level amplification of c-myc, together with a wild-type p53 gene, identified a subset of patients with locally advanced colorectal cancer showing increased disease-free and overall survival in response to 5FU-based adjuvant therapy (Augenlicht et al, 1997; Arango et al, 2001).